« Back
Home /
Suplatast (Tosilate)

Suplatast (Tosilate)

Item no.	TMO-T0117-500mg
Manufacturer	TargetMol
CASRN	94055-76-2
Amount	500 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 500 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	1. Mimura T, et al. J Pharmacol Exp Ther, 2005, 314(1), 293-301.
Smiles	CCOCC(COc1ccc(cc1)NC(=O)CC[S+](C)C)O.Cc1ccc(cc1)S(=O)(=O)[O-]
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	IPD 1151T,Suplatast Tosylate,Suplatast tosilate
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Interleukin\|\|\|IL Receptor
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	499.64
Description	Suplatast Tosilate (IPD 1151T) is a novel capsular anti-asthmatic drug with an IC50 above 100 μM, inhibiting both IgE production and the synthesis of IL-4 and IL-5.
Pathways	Immunology/Inflammation
Bioactivity	Suplatast Tosilate is a novel capsular anti-asthmatic agent that suppresses both IgE production, IL-4 and IL-5 synthesis with IC50 above 100 uM.
Receptor	Th2 cytokine

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T0117-500mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 500 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question